Price $10.38 |
Market Cap
10.35B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.16
|
P/S
0.67
|
Dividend %
-
|
|
P/CF
47.5
|
P/FCF
19.8
|
Op. Cash Flow
1.07M
|
FCF
0.4
|
|
Op. Margin
-7.70%
|
Net Margin
-8.50%
|
ROE
-13.80%
|
ROI
4.50%
|
|
ROA
-2.80%
|
EPS Growth
-276.70%
|
Current Ratio
1.1
|
Debt/Equity
210.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Statera Biopharma Inc (STAB) | $0.03 | - | - | 4.9M | Strong Buy |
| IM Cannabis Corp (IMCC) | $1.33 | - | - | 10.1M | Strong Buy |
| Humanigen Inc (HGEN) | $0.15 | - | - | 11.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.96 | - | - | 106.2M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.26 | - | - | 59M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
